Arrowhead Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 15.84 M | $306.74 M | 100.00% | 12.75% |
| VANGUARD GROUP INC | 11/13/2024 | 12.23 M | $236.88 M | 0.12% | 9.85% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 8.89 M | $172.18 M | 0.00% | 7.16% |
| STATE STREET CORP | 11/14/2024 | 6.35 M | $123.08 M | 8.85% | 5.12% |
| FMR LLC | 11/13/2024 | 6.07 M | $117.53 M | -10.93% | 4.89% |
| SLATE PATH CAPITAL LP | 11/14/2024 | 4.89 M | $94.62 M | 18.02% | 3.93% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 3.57 M | $69.24 M | 39.59% | 2.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.96 M | $57.43 M | 0.89% | 2.39% |
| SIREN, L.L.C. | 11/13/2024 | 2.46 M | $47.63 B | 100.00% | 1.98% |
| JPMORGAN CHASE & CO | 12/26/2024 | 2.15 M | $41.61 M | -7.22% | 1.73% |
| MORGAN STANLEY | 11/14/2024 | 1.61 M | $31.10 M | -11.54% | 1.29% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.27 M | $24.66 M | 0.75% | 1.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.18 M | $22.81 M | 24.16% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.01 M | $19.50 M | 1.26% | 0.81% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 866,399 | $16.78 M | -20.15% | 0.70% |
| WOODLINE PARTNERS LP | 11/14/2024 | 865,794 | $16.77 M | 5.39% | 0.70% |
| WESTERN FINANCIAL CORP/CA | 10/21/2024 | 820,239 | $15.89 M | 0.00% | 0.66% |
| AQUILO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 795,813 | $15.41 M | -12.40% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 645,604 | $12.51 M | 21.98% | 0.52% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 578,760 | $11.21 M | 10.45% | 0.47% |
| JANE STREET GROUP, LLC | 11/15/2024 | 463,880 | $8.99 M | -33.42% | 0.37% |
| UBS GROUP AG | 11/14/2024 | 441,511 | $8.55 M | 26.76% | 0.36% |
| ABRDN PLC | 10/25/2024 | 401,146 | $7.77 M | 61.32% | 0.32% |
| CENTERBOOK PARTNERS LP | 11/14/2024 | 394,578 | $7.64 M | 677.25% | 0.32% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 387,687 | $7.51 M | -5.54% | 0.31% |
| HOUND PARTNERS, LLC | 11/14/2024 | 378,708 | $7.34 M | 40.30% | 0.30% |
| RHUMBLINE ADVISERS | 11/12/2024 | 372,432 | $7.21 M | -2.77% | 0.30% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 355,000 | $6.88 M | 100.00% | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 350,000 | $6.78 M | 250.00% | 0.28% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 335,314 | $6.50 M | -0.81% | 0.27% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 333,356 | $6.46 M | 16.18% | 0.27% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 325,000 | $6.30 M | 550.00% | 0.26% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 315,373 | $6.11 M | 19.11% | 0.25% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 293,083 | $5.68 M | 232.48% | 0.24% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 290,994 | $5.64 M | -31.49% | 0.23% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 289,699 | $5.61 M | 8.88% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 287,282 | $5.56 M | 179.20% | 0.23% |
| BARCLAYS PLC | 11/19/2024 | 276,610 | $5.36 M | 153.65% | 0.22% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 265,923 | $5.15 M | -3.33% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 265,700 | $5.15 M | 1.65% | 0.21% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 255,871 | $4.96 M | 0.00% | 0.21% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 254,641 | $4.93 M | 0.37% | 0.21% |
| JOHNSON & JOHNSON | 11/13/2024 | 247,598 | $4.80 M | 0.00% | 0.20% |
| INVESCO LTD. | 11/12/2024 | 242,875 | $4.70 M | -6.43% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 231,300 | $4.48 M | 100.00% | 0.19% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 11/14/2024 | 224,889 | $4.36 M | 47.70% | 0.18% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 220,000 | $4.26 M | 22.22% | 0.18% |
| WCM INVESTMENT MANAGEMENT, LLC | 11/04/2024 | 219,962 | $4.33 M | -4.06% | 0.18% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 219,256 | $4.25 M | -70.30% | 0.18% |
| SWISS NATIONAL BANK | 11/07/2024 | 218,300 | $4.23 M | -10.28% | 0.18% |
Arrowhead Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 367 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 15.84 M
VANGUARD GROUP INC: 12.23 M
Avoro Capital Advisors LLC: 8.89 M
STATE STREET CORP: 6.35 M
FMR LLC: 6.07 M
Slate Path Capital LP: 4.89 M
77.10% of Arrowhead Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 130.14 M shares in the last 24 months. This purchase volume represents approximately $2.47 B in transactions.